Biomarin Pharmaceutical Inc

Skandinaviska Enskilda Banken AB (publ) BMRN

Report date

9/30/2025

Quarter

2025 Q3

Filed

11/7/2025

Shares

43,275

Value ($000)

2,343

Weight

0.0%

2019 Q4 - 2025 Q3 (24 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q3	11/7/2025	2,343	0.0%	43,275	9/30/2025
2025 Q2	8/13/2025	4,875	0.0%	88,698	6/30/2025
2025 Q1	5/7/2025	5,482	0.0%	77,598	3/31/2025
2024 Q4	2/10/2025	5,081	0.0%	77,598	12/31/2024
2024 Q3	11/7/2024	4,208	0.0%	59,869	9/30/2024
2024 Q2	8/13/2024	5,415	0.0%	65,775	6/30/2024
2024 Q1	5/13/2024	5,746	0.0%	65,775	3/31/2024
2023 Q4	2/14/2024	6,128	0.0%	63,564	12/31/2023
2023 Q3	11/9/2023	10,075	0.1%	113,869	9/30/2023
2023 Q2	8/7/2023	17,320	0.1%	199,816	6/30/2023
2023 Q1	5/11/2023	19,421	0.1%	199,718	3/31/2023
2022 Q4	2/8/2023	19,910	0.1%	192,385	12/31/2022
2022 Q3	11/14/2022	6,384	0.0%	75,306	9/30/2022
2022 Q2	8/10/2022	6,625	0.0%	79,950	6/30/2022
2022 Q1	5/11/2022	6,372	0.0%	82,647	3/31/2022
2021 Q4	2/10/2022	7,737	0.0%	86,861	12/31/2021
2021 Q3	11/10/2021	6,051	0.0%	78,291	9/30/2021
2021 Q2	8/10/2021	6,456	0.0%	77,369	6/30/2021
2021 Q1	5/14/2021	6,756	0.0%	89,469	3/31/2021
2020 Q4	2/11/2021	8,962	0.1%	102,201	12/31/2020
2020 Q3	11/12/2020	7,455	0.1%	97,984	9/30/2020
2020 Q2	8/13/2020	7,708	0.1%	62,497	6/30/2020
2020 Q1	5/13/2020	6,579	0.1%	77,859	3/31/2020
2019 Q4	2/14/2020	9,753	0.1%	115,350	12/31/2019